Tag Archives: Reimers

Undermining Bayh-Dole by relying on it? 5

Posted on March 14, 2022 by Gerald Barnett

Now for Reimers’s new op/ed, making more arguments against march-in, but now directed at Xtandi, a prostate cancer drug based on a series of compounds developed at UCLA with federal funding. According to Knowledge Ecology International, Xtandi is offered for … Continue reading →

Posted in Bayh-Dole | Tagged , , , | Comments Off on Undermining Bayh-Dole by relying on it? 5

Undermining Bayh-Dole by relying on it? 3

Posted on March 12, 2022 by Gerald Barnett

We are working through Niels Reimers’s op/ed in the Mercury News, published last April (2021) and now being used by the Bayh-Dole Coalition, a lobbying organization backed by a number of universities and front groups, to try to prevent Bayh-Dole’s … Continue reading →

Posted in Bayh-Dole, Technology Transfer | Tagged , , , | Comments Off on Undermining Bayh-Dole by relying on it? 3

Undermining Bayh-Dole by relying on it? 2

Posted on March 11, 2022 by Gerald Barnett

We are working through an op/ed published in April 2021 by Niels Reimers, one of the recognized university TLO leaders from the 1970s on. We are working through it now because the Bayh-Dole Coalition is using quotes from it to … Continue reading →

Posted in Bayh-Dole, Startups | Tagged , , , , , , , | Comments Off on Undermining Bayh-Dole by relying on it? 2

Undermining Bayh-Dole by relying on it? 1

Posted on March 10, 2022 by Gerald Barnett

I feel like Charlie Chaplin in a pie factory. Before I could work through an op/ed by Niels Reimers in the Mercury News last April (2021) that the Bayh-Dole Coalition has dredged up to contest the use of march-in to … Continue reading →

Posted in Bayh-Dole, Commons, Policy, Stanford v Roche, Technology Transfer | Tagged , , | Comments Off on Undermining Bayh-Dole by relying on it? 1